Moderna's Phase 3 COVID-19 Vaccine Shows 95% Efficacy
November 16, 2020 at 08:33 AM EST
Moderna announced on Monday the results from phase 3 trials for the COVID-19 vaccine show the vaccine is 94.5% effective.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.